From Nasdaq: 2025-06-16 01:40:00

Sinovac Biotech faces a lawsuit threatening $55 special dividend payment to shareholders by Advantech/Prime Success. The company will file an Opposition Brief today and has a hearing scheduled for June 18. The special cash dividend was declared in April with payment expected on or about July 9. Vivo Capital is challenging the dividend, causing disruption. Sinovac Biotech condemns the actions of the Dissenting Investor Group, who have already received $1.1 billion in dividends. An amount equal to the dividend for 2018 PIPE shares has been set aside in escrow, ensuring payment regardless of legal outcomes.



Read more at Nasdaq: SINOVAC To File Opposition Brief Against Advantech/Prime Success’ New Lawsuit